KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synopsys (SNPS) Other financing activities (2016 - 2025)

Historic Other financing activities for Synopsys (SNPS) over the last 13 years, with Q4 2025 value amounting to -$2.4 million.

  • Synopsys' Other financing activities changed N/A to -$2.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$2.9 million, marking a year-over-year decrease of 10396.18%. This contributed to the annual value of -$2.9 million for FY2025, which is 10396.18% down from last year.
  • Synopsys' Other financing activities amounted to -$2.4 million in Q4 2025.
  • Over the past 5 years, Synopsys' Other financing activities peaked at $48.0 million during Q1 2024, and registered a low of -$3.4 million during Q3 2021.
  • Its 5-year average for Other financing activities is $6.1 million, with a median of -$583500.0 in 2022.
  • Its Other financing activities has fluctuated over the past 5 years, first skyrocketed by 560409.84% in 2024, then plummeted by 10263.82% in 2025.
  • Synopsys' Other financing activities (Quarter) stood at -$3.4 million in 2021, then surged by 79.14% to -$704000.0 in 2022, then skyrocketed by 82.67% to -$122000.0 in 2023, then surged by 14485.25% to $17.6 million in 2024, then tumbled by 113.68% to -$2.4 million in 2025.
  • Its last three reported values are -$2.4 million in Q4 2025, -$463000.0 for Q3 2025, and $17.6 million during Q3 2024.